Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$95.9

Avg closing price
Price range

24 Paul Tudor Jones II Sarepta Therapeutics Trades

The first Sarepta Therapeutics trade was made in Q3 2015. Since then Paul Tudor Jones II bought shares eleven more times and sold shares on twelve occasions. The investor sold all their shares in Q1 2024 and doesn't own any shares in Sarepta Therapeutics anymore.

Avg closing price
Price range
Sold -62.8 Thousand shares Q1 2024
Avg closing price $122.50
Price range $93.70 - $141.53
New holding (+62.8 Thousand shares) Q4 2023
Avg closing price $95.93
Price range $67.31 - $124.76
Sold -14.6 Thousand shares Q2 2023
Avg closing price $128.95
Price range $106.40 - $157.19
Sold 52.1% shares (-15.9 Thousand shares) Q1 2023
Avg closing price $129.72
Price range $117.53 - $155.99
Sold 13.7% shares (-4.84 Thousand shares) Q4 2022
Avg closing price $115.88
Price range $100.39 - $132.13
New holding (+35.2 Thousand shares) Q3 2022
Avg closing price $100.79
Price range $75.71 - $119.24
Sold -4.38 Thousand shares Q2 2022
Avg closing price $73.57
Price range $62.69 - $88.44
Increased shares by 62.3% (+1.68 Thousand shares) Q1 2022
Avg closing price $76.58
Price range $63.15 - $90.42
New holding (+2.7 Thousand shares) Q4 2021
Avg closing price $85.49
Price range $77.28 - $99.42
Sold -56.7 Thousand shares Q3 2021
Avg closing price $77.03
Price range $65.97 - $92.48
Increased shares by 773.8% (+50.2 Thousand shares) Q2 2021
Avg closing price $75.81
Price range $69.38 - $86.75
Increased shares by 130.6% (+3.67 Thousand shares) Q1 2021
Avg closing price $92.28
Price range $72.25 - $168.95
New holding (+2.81 Thousand shares) Q4 2020
Avg closing price $148.17
Price range $125.56 - $178.74
Sold -14 Thousand shares Q3 2020
Avg closing price $151.97
Price range $127.12 - $172.34
New holding (+14 Thousand shares) Q2 2020
Avg closing price $136.08
Price range $93.00 - $171.70
Sold -40.8 Thousand shares Q3 2018
Avg closing price $136.70
Price range $115.31 - $161.51
New holding (+40.8 Thousand shares) Q2 2018
Avg closing price $94.30
Price range $71.74 - $153.69
Sold -27.5 Thousand shares Q3 2017
Avg closing price $39.97
Price range $33.89 - $47.15
Sold 66.0% shares (-53.4 Thousand shares) Q2 2017
Avg closing price $32.56
Price range $28.41 - $36.72
New holding (+80.9 Thousand shares) Q1 2017
Avg closing price $30.95
Price range $27.67 - $37.89

News about Sarepta Therapeutics Inc and Paul Tudor Jones II

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!